Health Care/Hospital
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition
BAD HOMBURG, Germany, Nov. 23, 2020 /PRNewswire/ -- Evidence indicates that omega-3 (ω-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,1 underlining its role in today's hospitals and clinics. To support continuous health ca...
2020-11-23 19:00
1597
Innovent Announces NMPA Granted New Indication Approval for SULINNO® (Adalimumab Injection) in China for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
SAN FRANCISCO and SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2020-11-23 18:34
9118
Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China
SUZHOU, China and ROCKVILLE, Md., Nov. 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
2020-11-23 18:32
1648
Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA™ Viral MagBead Kit
IRVINE, Calif., Nov. 23, 2020 /PRNewswire/ -- Zymo Research announced today that itsQuick-DNA/RNA™ Viral MagBead Kit was cleared for distribution to the European Union (EU) common market. Theproduct is designed for high-throughput purification of viral DNA and/or RNA from biological samples that ...
2020-11-23 14:05
2090
Picosun's medical ALD solutions enable safer surgeries
ESPOO, Finland, Nov. 23, 2020 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions, partners with prominent Chinese hospitals and researchers to apply medical ALD technology for safer surgical procedures. Picosun's biocompatible ...
2020-11-23 10:54
1227
Rewardz Empowers Employees with Joye - A Mental Wellness & Self-Care Offering
SINGAPORE, Nov. 23, 2020 /PRNewswire/ -- According to the World Health Organisation, COVID-19 has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health support continues to increase. It is evident that society and businesses must reco...
2020-11-23 10:00
1824
ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC
SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today announced that positive clinical data based on a pre-p...
2020-11-23 09:30
3411
CGTN: China calls for more inclusive development in post-COVID world
BEIJING, Nov. 23, 2020 /PRNewswire/ -- With COVID-19 still causing widespread damage across the world,China on Saturday called for concerted efforts from major economies to promote more inclusive development and improve global governance in the post-pandemic era.   Read the ori...
2020-11-23 09:09
2187
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowle...
2020-11-23 09:00
2056
Infinitus Harnesses eCommerce to Offer Greater Direct Selling Opportunities for Partners
GUANGZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Ahead of key eCommerce festivals such as 11.11 and Black Friday, Infinitus (China) Company Ltd ("Infinitus"), a purveyor of health products and solutions, has harnessed the power of social e-Commerce to open up new direct selling opportunities for ...
2020-11-23 09:00
1856
G20 Riyadh Summit: Release of Leaders' Declaration
RIYADH, Saudi Arabia, Nov. 23, 2020 /PRNewswire/ -- G20 Leaders endorsed their declaration at the end of their summit todayNovember 22, 2020, including agreements on steps to be taken to protect lives and shape a better future. "We, the G20 Leaders, meeting for the second time under the Saudi Pr...
2020-11-23 08:30
1364
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
SAN FRANCISCO and SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2020-11-23 08:00
5474
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange
HONG KONG, Nov. 20, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer medicines, today announced that the company was officially listed and it's shares commenced trading on the Main Board...
2020-11-20 21:09
12797
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease
RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy The Phase 3 study is expected to recruit up to 125 patients across approximately 40 U.S. clinical sites RHB-...
2020-11-20 21:00
5244
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting
Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients PLYMOUTH MEETING, Pa., Nov. 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely de...
2020-11-20 21:00
5422
Ortho's CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals
- Ortho's VITROS® SARS-CoV-2 antigen test can detect SARS-CoV-2 infection in asymptomatic individuals. - The low-cost VITROS antigen test can run up to 130 tests per hour and is a viable choice for frequent, high-throughput testing and monitoring of large community populations. RARITAN, N.J., N...
2020-11-20 20:00
1469
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou
HANGZHOU, China, Nov. 20, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced its biologics integrated innovation center has been in operation inHangzhou, Zhejiang province, China. From process deve...
2020-11-20 16:30
1907
Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine
SINGAPORE, Nov. 20, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare services provider inAsia, announced that it will significantly expand its cold storage warehouse capacity in key regional markets over the next 12 months. As the largest vaccines and cold chain pharmaceutical distributo...
2020-11-20 15:31
5568
Indonesian Government Presents Education on COVID-19 Vaccines
JAKARTA, Indonesia, Nov. 20, 2020 /PRNewswire/ -- The government, through the COVID-19 Handling and Economic Recovery (KPCPEN) continues to battle the COVID-19 pandemic inIndonesia by accelerating the preparation of the Sinovac vaccine, which is currently entering stage III clinical trials and h...
2020-11-20 15:28
1545
Huize Announces 2020 Third Quarter Results
GWP and Total Operating Revenue Achieved Double-Digit YOY Growth Hitting Record Quarterly Highs Results Highlights: * GWP facilitated on our platform increased by 41.2% to a record quarterly high of RMB779.0 million, compared to RMB551.8 million in the third quarter of 2019. * Total operat...
2020-11-20 15:10
10656
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 312 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 306 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 290 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14378
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9999
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9532
